Articles

A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification

Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany;
Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany;
Hannover Medical School and dept. of Stem Cell Discovery, Novo Nordisk, Denmark;
German Cancer Research Center (DKFZ) Heidelberg Institute for Stem Cell Technology, Germany;
Institute of Molecular Biology, Hannover Medical School, Hannover, Germany;
Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany;
Institute of Molecular Biology, Hannover Medical School, Hannover, Germany;
REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany;
Institute for Pathology, Hannover Medical School, Hannover, Germany;
Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Germany;
REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Germany;
REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Germany;
Institute of Molecular Biology, Hannover Medical School, Hannover, Germany;
German Cancer Research Center and Heidelberg Institute for Stem Cell Technology, Germany
Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany;
Haematologica Early view Apr 23, 2020 https://doi.org/10.3324/haematol.2019.228064